New study published in The Journal of Neuroscience highlights disease-modifying potential of Neurodon’s SERCA activators for Alzheimer’s disease
Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder characterized by disrupted calcium signaling, synaptic dysfunction, and cognitive decline. Dysregulated calcium signaling is a key driver of AD pathogenesis, but previous efforts targeting calcium signaling proteins have been challenging due to potential side effects. Neurodon’s industry-leading positive allosteric modulators (PAMs) of the SERCA pump offer a […]